comparemela.com

Patent Claims News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seagen Requests Director Review Of Unpatentability Decision In Adcetris® Patent PGR

On February 14, 2024, Seagen requested director review of the PTAB s January 16th Final Written Decision in PGR2021-00030 finding antibody-drug conjugate claims in U.S. Patent No. 10,808,039 .

Seagen adcetrisApril breyer menonFinal written decisionPatent claimsBreyer menon

Scope Of Issued Patents May Be Limited By Prosecution Estoppel Created In Child Cases - Patent

Cell therapy products in the U.S. are estimated to be worth approximately $4.5 billion currently and expected to grow to over $30 billion in the next ten years.

United statesWhitehead instituteFate therapeuticsShoreline biosciencesProsecution historyWhile fateProsecution history estoppelHistory estoppelFederal circuitIntellectual propertyLife sciencesPatent claimsPatent infringementPatent lawPatent litigationProsecution history estoppel

CAFC Orders Review of Extrinsic Evidence to Determine Proper Limit of Claimed pH Range

Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. vacating an infringement judgment against Mylan in the Northern District of West Virginia.

West virginiaUnited statesUs food drug administrationActelion pharmaceuticals ltdMylan pharmaceuticals incMylan pharmaceuticalsUs courtFederal circuitActelion pharmaceuticalsNorthern districtAbbreviated new drug applicationDrug administrationOrange book listedEpoprostenol formulationPatent claimsSpecification require review

Apple continues to refine one of their Smart Ring patents for future Macs, Smartglasses, TV, iPhone & more

Apple continues to refine one of their Smart Ring patents for future Macs, Smartglasses, TV, iPhone & more
patentlyapple.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from patentlyapple.com Daily Mail and Mail on Sunday newspapers.

Trademark officeVision proApple watchApple vision proFuture appleFew pointsPatent claimsPatent report

Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Call Transcript

Liquidia Corporation (NASDAQ:LQDA) Q2 2023 Earnings Call Transcript August 10, 2023 Liquidia Corporation misses on earnings expectations. Reported EPS is $-0.36 EPS, expectations were $-0.17. Operator: Good morning, and welcome everyone to the Liquidia Corporation Second Quarter 2023 Financial Results and Corporate Update Conference Call. My name is Livia, and I will be your conference […]

United statesMike kasetaPharmosa biopharmaRoger jeffsUnited states supreme courtDistrict courtNational cancer institute on unsplashNational cancer instituteFederal circuitPatent trialAppeal boardUnited states supremeOrange bookChief medical officerRajeev saggarNorth american

vimarsana © 2020. All Rights Reserved.